MedTrace Logo

Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients With Heart Failure and Preserved Ejection Fraction

NCT01989299 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2022-05-23

No results posted yet for this study

Summary

Heart failure with preserved ejection fraction (HFPEF) is a large medical problem, for which no drug or device has a recommendation in current heart failure guidelines. Sudden cardiac death is suggested as the most common cause of death in HFPEF patients, although data is sparse. Use of an Implantable Loop Recorder (ILR) may be useful in patients with HFPEF to evaluate the incidence of sustained ventricular tachyarrhythmias. If ventricular tachyarrhythmias are seem frequently, treatment with an Implantable Cardioverter Defibrillator (ICD) may be an option in the future.

Conditions

  • Heart Failure With Preserved Ejection Fraction (HFpEF)

Interventions

DEVICE

ILR implantation

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Michiel Rienstra, MD, PhD · University Medical Center Groningen

  • Isabelle C van Gelder, MD, PhD · University Medical Center Groningen

  • Alexander H Maass, MD, PhD · University Medical Center Groningen

  • Dirk J Veldhuisen, van, MD, PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2019-12-31
Completion
2020-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01989299 on ClinicalTrials.gov